Abstract
Mouse mammary tumor virus (MMTV) is a classic example of a latently oncogenic retrovirus, its life cycle and tumorigenicity showing many parallels with the leukemia viruses of domestic cats, chickens and laboratory mice (1). Although indisputably linked to the development of particular cancers, such viruses do not themselves encode the oncogenes responsible for cell transformation. Epidemiologically, they are therefore very different from the various isolates of acutely oncogenic retroviruses, in which cellular proto-oncogene sequences have become transduced within the viral genomes (2). While the latter transform cells rapidly and efficiently, both in vitroand in vivo, the latently oncogenic viruses have little or no influence on cultured cells, and in the animal there is characteristically a long delay between exposure of the virus and overt manifestations of neo-plasia. With MMTV, mice are naturally infected by milk-borne virus at birth, yet tumors rarely arise before about 4 months of age, the norm being closer to 6 to 9 months (3,4; and chapter by Slagle and Butel). Most female mice are detectably viremic at pregnancy, and shed high levels of virus in the milk, but although a high proportion of the mammary epithelial cells can become productively infected, they remain apparently normal. Indeed, only very rare infected cells undergo transformation and expand clonally to dominate the resultant tumors, suggesting some stochastic process as opposed to a direct influence of a viral gene product
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Teich, N., Wyke, J., Mak, T., Bernstein, A., and Hardy, W. Pathogenesis of retrovirus-induced disease. In:R. Weiss, N. Teich, H. Varums, and J. Coffin (eds.), Molecular Biology of Tumor Viruses, Part III, RNA Tumor Viruses, p. 785–998. Cold Spring Harbor Laboratory, 1982.
Bishop, J.M. Cellular oncogenes and retroviruses. Ann. Rev. Biochem. 52: 301 – 354, 1983.
Cardiff, R.D., and Young, L.J.T. Mouse mammary tumor biology: A new synthesis. In:M. Essex, G. Todaro, and H. zur Hausen (eds.), Viruses in Naturally Occurring Cancers, p. 1105–1114. Cold Spring Harbor Laboratory, 1980.
Moore, D.H., Long, C.A., Vaidya, A.B., Sheffield, J.B., Dion, A.S., and Lafargues, E.Y. Mammary tumor viruses. Adv. Cancer Res. 29: 347 – 418, 1979.
Cohen, J.C., Shank, P.R., Morris, V.L., Cardiff, R., and Varmus, H.E. Integration of the DNA of mouse mammary tumor virus in virus-in-fected normal and neoplasic tissue of the mouse. Cell 16: 337 – 345, 1979.
Cohen, J.C. and Varmus, H.E. Proviruses of mouse mammary tumor virus in normal and neoplastic tissues of GR and C3H+ mouse strains. J. Virol. 35: 298 – 305, 1980.
Fanning, T.G., Puma, J.P., and Cardiff, R.D. Selective amplification of mouse mammary tumor virus in mammary tumors of GR mice. J. Virol. 36: 109 – 114, 1980.
Groner, B., Buetti, E., Diggelmann, H., and Hynes, N.E. Characterization of endogenous and exogenous mouse mammary tumor virus proviral DNA with site-specific molecular clones. J. Virol. 36: 734 – 745, 1980.
Nusse, R. and Varmus, H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99 – 109, 1982.
Peters, G., Brookes, S., Smith, R., and Dickson, C. Tumorigenesis by mouse mammary tumor virus: evidence for a common region for pro-virus integration in mammary tumors. Cell 33: 369 – 377, 1983.
Varmus, H. Replication of retroviruses. In: R. Weiss, N. Teich, H. Varmus, and J. Coffin (eds.), Molecular Biology of Tumor Viruses, Part III. RNA Tumor Viruses. p. 268 – 512. Cold Spring Harbor Laboratory, 1982.
Varmus, H.E. The molecular genetics of cellular oncogenes. Ann. Rev. Genet. 18: 553 – 612, 1984.
Nusse, R., van Ooyen, A., Cox, R., Fung, Y.-K.T., and Varmus, H. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131 – 136, 1984.
Dickson, C., Smith, R., Brookes, S., and Peters, G. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37: 529 – 536, 1984.
Garcia, M., Wellinger, R., Versaz, A., and Diggelmann, H. A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/c+ (C3H) mammary and kidney adenocarcinomas. EMBO J. 5: 127 – 134, 1986.
Peters, G., Lee, A.E., and Dickson, C. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumor virus. Nature 320: 628 – 631, 1986.
Peters, G., Kozak, C., and Dickson, C. Mouse mammary tumor virus in-tegration regions int-1and int-2map on different chromosomes. Mol. Cell. Biol. 4: 375 – 378, 1984.
Van Ooyen, A., and Nusse, R. Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein coding domain intact. Cell 39: 233 – 240, 1984.
Rijsewijk, F.A.M., van Lohuizen, M., Van Ooyen, A., and Nusse, R. Construction of a retroviral cDNA version of the int-1mammary oncogene and its expression in vitro. Nucleic Acids Res. 14: 693 – 702, 1986.
Fung, Y.-K.T., Shackleford, G.M., Brown, A.M.C., Sanders, G.S., and Varmus, H.E. Nucleotide sequence and expression in vitroof cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene. Mol. Cell. Biol. 5: 3337 – 3344, 1985.
Moore, R., Casey, G., Brookes, S., Dixon, M., Peters, G., and Dickson, C. Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumor virus. EMBO J. In: Press, 1986.
Hayward, W.S., Neel, B.G., and Astrin, S.M. Activation of a cellular oncogene by promoter insertion in ALV induced lymphoid leukosis. Nature 290: 475 – 480, 1981.
Fung, Y.-K.T., Fadly, A.M., Crittenden, L.B., and Kung, H.-J. On the mechanism of retrovirus-induced avian lymphoid leukosis: deletion and integration of the proviruses. Proc. Natl. Acad. Sci. USA 81: 34180 – 3422, 1981.
Payne, G.S., Courtneidge, S.A., Crittenden, L.B., Fadly, A.M., Bishop, J.M., and Varmus, H.E. Analysis of avian leukosis virus DNA and RNA in bursal tumors: viral gene expression is not required for maintenance of the tumor state. Cell 23: 311 – 322, 1981.
Payne, G.S., Bishop, J.M., and Varmus, H.E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature 295: 209 – 214, 1982.
Chandler, V.L., Maler, B.A., and Yamamoto. K.R. DNA sequences bound specifically by glucocorticoid receptor in vitrorender a heterologous promoter hormone responsive in vivo. Cell 33: 489 – 499, 1983.
Ponta, H., Kennedy, N., Stroch, P., Hynes, N.E., and Groner, B. Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. Proc. Natl. Acad. Sci. USA 82: 1020 – 1024, 1985.
Stewart, T.A., Pattengale, P.K., and Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627 – 637, 1984.
Rosen, C.A., Haseltine, W.A., Lenz, J., Ruprecht, R., and Lloyd, M.W. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55: 862 – 866, 1985.
Wasylyk, B., Wasylyk, C., Augereau, P., and Chambon, P. The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements. Cell 32: 503 – 514, 1983.
de Villiers, J., Olsen, L., Banerji, J., and Schaffner, W. Analysis of the transcriptional enhancer effect. In: Cold Spring Harbor Symposia on Quantitative Biology 46: 911 – 919, 1982.
Nilsen, T.W., Maroney, P.A., Goodwin, R.G., Rottman, F.M., Crittenden, L.B., Raines, M.A., and Kung, H. C-erb Bactivation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell 41: 719 – 726, 1985.
Shen-Ong, G.L.C., Morse, H.C., Potter, M., and Mushinski, J.F. Two modes of c-mybactivation in virus-induced mouse myeloid tumors. Mol. Cell. Biol. 6: 380 – 392, 1986.
Zarbl, H., Sukumar, S., Arthur, A., Martin-Zanca, D., and Barbacid, M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rat. Nature 315: 382 – 385, 1985.
Peters, G., Lee, A., and Dickson, C. Activation of cellular gene by mouse mammary tumor virus may occur early in mammary tumor development. Nature 309: 273 – 275, 1984.
Van Veer, L., van Kessel, A.G., van Heerikhuizen, H., Van Ooyen, A., and Nusse, R. Molecular cloning and chromosomal assignment of the human homolog of int-1, a mouse gene implicated in mammary tumori-genesis. Mol. Cell. Biol. 4: 2532 – 2534, 1984.
Van Ooyen, A., Kwee, V., and Nusse, R. The nucleotide sequence of the human int-1mammary oncogene; evolutionary conservation of coding and non-coding sequences. EMBO J. 4: 2905 – 2909, 1985.
Casey, G., Smith, R., McGillivray, D., Peters, G., and Dickson, C. Characterization and chromosome assignment of the mouse homolog of int-2, a potential proto-oncogene. Mol. Cell. Biol. 6: 502 – 510, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Peters, G., Dickson, C. (1987). On the Mechanism of Carcinogenesis by Mouse Mammary Tumor Virus. In: Medina, D., Kidwell, W., Heppner, G., Anderson, E. (eds) Cellular and Molecular Biology of Mammary Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0943-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0943-7_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42761-9
Online ISBN: 978-1-4613-0943-7
eBook Packages: Springer Book Archive